![]() |
|
|
Vol. 283, Issue 3, 1544-1551, 1997
Departments of
Pharmacology and Physiology (R.A.I., M.W.A.) and
of
Laboratory Animal Medicine (R.B.B.), University of Rochester,
Rochester, New York
2-(Fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (Compound A) is
a halogenated alkene that is nephrotoxic in rats when administered by
inhalation or intraperitoneally. Compound A undergoes
glutathione-dependent metabolism: Compound A-derived glutathione
S-conjugates and mercapturates are excreted in the bile
and urine, respectively, of rats given Compound A. The present
experiments were designed to study the nephrotoxicity of the Compound
A-derived glutathione and cysteine S-conjugates,
S-[2-(fluoromethoxy)-1,1,3,3,3-pentafluoropropyl]glutathione 2,
S-[2-(fluoromethoxy)-1,3,3,3-tetrafluoro-1-propenyl]glutathione 3,
S-[2-(fluoromethoxy)-1,1,3,3,3-pentafluoropropyl]-L-cysteine 4 and
S-[2-(fluoromethoxy)-1,3,3,3-tetrafluoro-1-propenyl]-L-cysteine 5. Conjugates 2, 3 and 4 given intraperitoneally produced dose-dependent nephrotoxicity that was
characterized by diuresis, increased excretion of glucose and protein,
elevated blood urea nitrogen concentrations and severe morphological
changes in the kidneys, particularly in the proximal tubules.
Glutathione S-conjugate 2, at a dose of 500 µmol/kg, was hepatotoxic. Cysteine S-conjugate
5 was not nephrotoxic, apparently because of its facile
cyclization to the thiazoline
2-[1-(fluoromethoxy)-2,2,2-trifluoroethyl]-4,5-dihydro-1,3-thiazole-4-carboxylic acid, which is not a
-lyase substrate. Also, the
-methyl analog of cysteine S-conjugate 4 S-[2-(fluoromethoxy)-1,1,3,3,3-pentafluoropropyl]-DL-
-methylcysteine, which cannot undergo
-lyase-dependent bioactivation, was not nephrotoxic. These in vivo data show that Compound
A-derived S-conjugates are nephrotoxic and that the
toxicity is associated with
-lyase-dependent bioactivation.
This article has been cited by other articles:
![]() |
E. D. Kharasch, J. L. Schroeder, T. Bammler, R. Beyer, and S. Srinouanprachanh Gene Expression Profiling of Nephrotoxicity from the Sevoflurane Degradation Product Fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl Ether ("Compound A") in Rats Toxicol. Sci., April 1, 2006; 90(2): 419 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Altuntas and E. D. Kharasch Biotransformation of L-Cysteine S-Conjugates and N-Acetyl-L-Cysteine S-Conjugates of the Sevoflurane Degradation Product Fluoromethyl-2,2-Difluoro-1-(trifluoromethyl)vinyl Ether (Compound A) in Human Kidney in Vitro: Interindividual Variability in N-Acetylation, N-Deacetylation, and beta -Lyase-Catalyzed Metabolism Drug Metab. Dispos., February 1, 2002; 30(2): 148 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Kharasch, E. J. Frink Jr., A. Artru, P. Michalowski, G. A. Rooke, and W. Nogami Long-Duration Low-Flow Sevoflurane and Isoflurane Effects on Postoperative Renal and Hepatic Function Anesth. Analg., December 1, 2001; 93(6): 1511 - 1520. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kraus, V. Uttamsingh, M.W. Anders, and S. Wolf Porcine Kidney Microsomal Cysteine S-Conjugate N-Acetyltransferase-Catalyzed N-Acetylation of Haloalkene-Derived Cysteine S-Conjugates Drug Metab. Dispos., April 1, 2000; 28(4): 440 - 445. [Abstract] [Full Text] |
||||
![]() |
R. I. Mazze, C. M. Callan, S. T. Galvez, L. Delgado-Herrera, and D. B. Mayer The Effects of Sevoflurane on Serum Creatinine and Blood Urea Nitrogen Concentrations: A Retrospective, Twenty-Two-Center, Comparative Evaluation of Renal Function in Adult Surgical Patients Anesth. Analg., March 1, 2000; 90(3): 683 - 688. [Abstract] [Full Text] [PDF] |
||||